|
The Addario Lung Cancer Medical Institute (ALCMI voiced as Alchemy) is a patient-founded non-profit research consortium established to help make lung cancer a survivable disease. Founded by advanced stage lung cancer patient Bonnie J. Addario, founder of the Bonnie J. Addario Lung Cancer Foundation, .
History ALCMI was incorporated in early 2008,[1] and in September 2008 recruited Steven Young as President & Chief Operating Officer (former Executive Director, Multiple Myeloma Research Consortium). In January 2009 ALCMI's Scientific Leadership Board was established, composed of many of the world's leading lung cancer researchers, clinicians and scientists. On July 31, 2009, ALCMI entered a diagnostic screening and clinical research agreement with Response Genetics, Inc. for the molecular testing and banking of advanced stage lung cancer tissue samples.[2] In addition, ALCMI has partnered with both academic institutions, such as UCSF, NYU, Vanderbilt University, UC Davis, the Dana-Farber Cancer Institute, and the University of Southern California, and community hospitals such as Hoag Hospital, Lahey Clinic and Alta Bates Summit Medical Center. ALCMI has established an international biorepository.[3] Executive Board - President & COO - Steven Young
- CEO - Tony Addario
Scientific Leadership Board - David Carbone, MD, PhD, SLB Chair (Vanderbilt University)
- Bonnie J. Addario
- David R. Gandara, MD (University of California at Davis)
- David Jablons, MD (University of California San Francisco)
- Pasi A. Janne, MD (Dana-Farber Cancer Institute)
- Ite Laird-Offringa, PhD (University of Southern California)
- Harvey I. Pass, MD (New York University)
- Rafael Rosell, MD, PhD (Catalan Institute of Oncology)
- Jean-Charles Soria, MD, PhD (Institute Gustave Roussy)
- Giorgio Scagliotti, MD, PhD (University of Torino)
Board of Directors - Tony Addario (Chair)
- Scott Santarella (Vice-Chair)
- Bonnie J. Addario
- Samuel Bain
- Bruce Gellman
- Jamie Gorenberg
- Pankaj Patel
External links References
|
Encyclopedia
top
